Atrinsic (PTIX) Competitors $3.26 +0.02 (+0.62%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$3.28 +0.03 (+0.77%) As of 07/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PTIX vs. SVT, TSBX, BFRI, OBSV, BMRA, CDIO, NLSP, RNAZ, JBIO, and PMCBShould you be buying Atrinsic stock or one of its competitors? The main competitors of Atrinsic include Servotronics (SVT), Turnstone Biologics (TSBX), Biofrontera (BFRI), ObsEva (OBSV), Biomerica (BMRA), Cardio Diagnostics (CDIO), NLS Pharmaceutics (NLSP), TransCode Therapeutics (RNAZ), Jade Biosciences (JBIO), and Nuvilex (PMCB). Atrinsic vs. Its Competitors Servotronics Turnstone Biologics Biofrontera ObsEva Biomerica Cardio Diagnostics NLS Pharmaceutics TransCode Therapeutics Jade Biosciences Nuvilex Servotronics (NYSEAMERICAN:SVT) and Atrinsic (NASDAQ:PTIX) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Which has higher earnings & valuation, SVT or PTIX? Servotronics has higher revenue and earnings than Atrinsic. Atrinsic is trading at a lower price-to-earnings ratio than Servotronics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioServotronics$44.92M2.68-$1.62M$0.05938.99AtrinsicN/AN/A-$5.53M-$13.11-0.25 Is SVT or PTIX more profitable? Atrinsic has a net margin of 0.00% compared to Servotronics' net margin of -2.32%. Servotronics' return on equity of -1.23% beat Atrinsic's return on equity.Company Net Margins Return on Equity Return on Assets Servotronics-2.32% -1.23% -0.82% Atrinsic N/A -860.52%-354.19% Which has more risk & volatility, SVT or PTIX? Servotronics has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Atrinsic has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500. Does the media refer more to SVT or PTIX? In the previous week, Atrinsic had 1 more articles in the media than Servotronics. MarketBeat recorded 1 mentions for Atrinsic and 0 mentions for Servotronics. Atrinsic's average media sentiment score of 1.87 beat Servotronics' score of 0.00 indicating that Atrinsic is being referred to more favorably in the news media. Company Overall Sentiment Servotronics Neutral Atrinsic Very Positive Do insiders & institutionals believe in SVT or PTIX? 24.8% of Servotronics shares are owned by institutional investors. Comparatively, 8.0% of Atrinsic shares are owned by institutional investors. 33.9% of Servotronics shares are owned by insiders. Comparatively, 35.0% of Atrinsic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryServotronics beats Atrinsic on 7 of the 12 factors compared between the two stocks. Get Atrinsic News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTIX vs. The Competition Export to ExcelMetricAtrinsicMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.91M$3.07B$5.70B$9.50BDividend YieldN/A2.37%4.60%4.01%P/E Ratio-0.2521.1828.1020.05Price / SalesN/A286.99429.3789.38Price / CashN/A42.7636.2258.56Price / Book1.668.378.665.87Net Income-$5.53M-$55.19M$3.25B$258.55M7 Day Performance-4.68%5.88%4.22%3.73%1 Month Performance-15.76%17.33%10.51%11.75%1 Year Performance-66.80%4.42%34.40%18.03% Atrinsic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTIXAtrinsic0.5277 of 5 stars$3.26+0.6%N/A-68.3%$1.91MN/A-0.252Positive NewsSVTServotronicsN/A$46.94flatN/AN/A$120.17M$44.92M-109.16270TSBXTurnstone Biologics3.4257 of 5 stars$0.36-2.0%$0.45+24.7%-85.7%$8.35MN/A-0.1382Positive NewsGap DownBFRIBiofrontera3.0515 of 5 stars$0.86flat$2.75+219.8%-3.6%$8.12M$38.00M-0.3870Positive NewsGap UpOBSVObsEvaN/AN/AN/AN/A$7.94MN/A-0.1150BMRABiomerica1.2724 of 5 stars$3.03-3.8%N/A+39.9%$7.73M$5.41M-1.3160Positive NewsCDIOCardio Diagnostics3.4683 of 5 stars$4.42+6.5%$60.00+1,257.5%-68.0%$7.69M$19.90K0.001Positive NewsNLSPNLS PharmaceuticsN/A$2.13+1.4%N/A+909.2%$7.67MN/A0.006Positive NewsGap DownRNAZTransCode Therapeutics2.7156 of 5 stars$9.11+4.8%$280.00+2,973.5%-99.9%$7.59MN/A0.009Positive NewsJBIOJade Biosciences2.4161 of 5 stars$9.00-8.4%$15.00+66.7%N/A$7.57MN/A-0.1520PMCBNuvilex3.0316 of 5 stars$1.10+1.9%N/A-52.7%$7.55MN/A1.494Positive NewsGap Down Related Companies and Tools Related Companies Servotronics Alternatives Turnstone Biologics Alternatives Biofrontera Alternatives ObsEva Alternatives Biomerica Alternatives Cardio Diagnostics Alternatives NLS Pharmaceutics Alternatives TransCode Therapeutics Alternatives Jade Biosciences Alternatives Nuvilex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTIX) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrinsic Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atrinsic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
